Cancer Risk: Vaccines & Hereditary Syndromes

Promising Vaccine Offers New Hope for Preventing Lynch Syndrome-Related Cancers In a landmark development for preventative oncology, researchers have demonstrated the safety and ability of an “off-the-shelf” neoantigen vaccine to stimulate an immune response in individuals carrying the genetic mutations associated with Lynch syndrome. This breakthrough, detailed in a study published in Nature Medicine, represents … Read more

Zolgensma Repeat Dose: SMA Treatment Outcomes & Safety

New Hope for Spinal Muscular Atrophy: Phase 3 Trial Shows Promise of Intrathecal Gene Therapy In a significant advancement for the treatment of spinal muscular atrophy (SMA), results from the Phase 3 STRENGTH study indicate that intrathecal onasemnogene abeparvovec demonstrates a favorable safety profile and offers a potential new therapeutic avenue for individuals affected by … Read more